Access
This article is part of Nature's premium content.
Published online 26 July 2006 | Nature | doi:10.1038/news060724-8
News
Clinical-use stem cells made in Singapore
Lines designed for safe use in humans make their debut.
Four 'safe' embryonic stem-cell lines, which have been made from scratch specifically for clinical use, make their debut this week. Singapore-based biotech company ESI will announce on 27 July the existence of these lines, plus four more in the pipeline, and have said they will make them available to researchers worldwide by the end of this year.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.